L’anticorps Souris Monoclonal anti-ERCC1 a été validé pour WB, IF, ICC et IHC (p). Il convient pour détecter ERCC1 dans des échantillons de Humain. Il y a 8+ publications disponibles.
ERCC1
Reactivité: Humain, Souris, Rat
WB, ELISA, IHC, IF, ICC
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Laufs, Altieri, Sbiera, Kircher, Steinhauer, Beuschlein, Quinkler, Willenberg, Rosenwald, Fassnacht, Ronchi: "ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas." dans: European journal of endocrinology, Vol. 178, Issue 2, pp. 181-188, (2018) (PubMed).
Kuo, Adam, Dorvault, Robin, Friboulet, Soria, Olaussen: "A novel antibody-based approach to detect the functional ERCC1-202 isoform." dans: DNA repair, Vol. 64, pp. 34-44, (2018) (PubMed).
Bahamon, Gao, Danaee: "Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors." dans: Archives of pathology & laboratory medicine, Vol. 140, Issue 12, pp. 1397-1403, (2016) (PubMed).
Xiu, Jiang, Liu: "Classic biphasic pulmonary blastoma with brain and axillary metastases: a case report with molecular analysis and review of literature." dans: International journal of clinical and experimental pathology, Vol. 8, Issue 1, pp. 983-8, (2015) (PubMed).
Puccetti, Fallarino, Italiano, Soubeyran, MacGrogan, Debled, Velasco, Bodet, Eimer, Veldhoen, Prendergast, Platten, Bessede, Guillemin: "Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers." dans: PLoS ONE, Vol. 10, Issue 4, pp. e0122046, (2015) (PubMed).
Smith, Fiehn, Fogh, Christensen, Hansen, Stenvang, Nielsen, Nielsen, Hasselby, Brünner, Jensen: "Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody." dans: Scientific reports, Vol. 4, pp. 4313, (2014) (PubMed).
Bauman, Austin, Schmidt, Kurland, Vaezi, Hayes, Mendez, Parvathaneni, Chai, Sampath, Martins: "ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial." dans: British journal of cancer, Vol. 109, Issue 8, pp. 2096-105, (2013) (PubMed).
Ma, Baruch, Shu, Yuan, Sun, Ma, Hoang, Fu, Min, Lan, Wang, Mull, He: "Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology." dans: BMC biotechnology, Vol. 12, pp. 88, (2012) (PubMed).